Literature DB >> 6147830

Behavioural correlates to the dopamine D-1 and D-2 antagonists.

A V Christensen, J Arnt, J Hyttel, O Svendsen.   

Abstract

The acute dopamine (DA) receptor blockade of neuroleptics can be demonstrated in mice by antagonism of stereotypies induced by the DA-agonist methylphenidate and in rats by antagonism of stereotypies induced by the DA-agonists amphetamine or apomorphine. Neuroleptics such as the thioxanthene, cis(Z)-flupentixol, the phenothiazine, fluphenazine, the butyrophenone, haloperidol and the benzamide clebopride are equipotent behaviourally as well as clinically. Also the D-1 receptor-antagonist SCH 23390 has the same pharmacological effects. In a series of experiments where the methylphenidate-induced stereotyped gnawing in mice was inhibited by neuroleptics it was shown that the effect of butyrophenones was greatly attenuated by concomitant treatment with scopolamine and diazepam. Similar results were obtained in rats experiments. The effect of phenothiazines was less influenced and that of thioxanthenes and SCH 23390 remained nearly unchanged. Besides, a clear differentiation of these drugs was seen when they were tested in mice rendered supersensitive by 12 days treatment with different neuroleptics. In the withdrawal phase the decrease effects against methylphenidate were shown by increased ED50 values for methylphenidate antagonism and an increased response to methylphenidate. The thioxanthenes and SCH 23390 retained the ability to antagonize the stereotyped gnawing, the phenothiazines showed a reduced effect, whereas the butyrophenones showed both tolerance and cross tolerance to the stereotyped behaviour. This behavioural classification of neuroleptics into three different groups is comparable with the classification obtained by DA-receptor binding techniques in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6147830

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  7 in total

1.  Effects of high doses of theophylline on memory acquisition.

Authors:  M R Zarrindast; N Jamali-Raeufy; B Shafaghi
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  DSP4 alters the effect of d-amphetamine on variable-interval performance: analysis in terms of Herrnstein's equation.

Authors:  M J Morley; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Attenuation by pimozide of the suppressant effect of d-amphetamine on operant behaviour.

Authors:  M J Morley; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.

Authors:  H Lublin; J Gerlach; L Peacock
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.

Authors:  H Rollema; M G Feenstra; C J Grol; M H Lewis; L Staples; R B Mailman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

6.  Effect of 6-hydroxydopamine-induced lesions of the dorsal noradrenergic bundle on steady-state operant behaviour.

Authors:  M J Morley; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Selective D-1 dopamine receptor agonist treatment of Parkinson's disease.

Authors:  A Braun; G Fabbrini; M M Mouradian; C Serrati; P Barone; T N Chase
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.